COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 786
[34] De Palma G, Nadal I, Medina M, et al. Intestinal dysbiosis and
reduced immunoglobulin-coated bacteria associated with
coeliac disease in children. BMC Microbiol. 2010;10:63.
[35] Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in
European women with normal, impaired and diabetic glucose
control. Nature. 2013;498(7452):99-103.
[36] Hevia A, Milani C, López P, et al. Intestinal dysbiosis associated
with systemic lupus erythematosus. mBio. 2014;5(5).
[37] Vogt NM, Kerby RL, Dill-McFarland KA, et al. Gut microbiome
alterations in Alzheimer's disease. Sci Rep. 2017;7(1):13537.
[38] Martín R, Miquel S, Benevides L, et al. Functional
characterization of novel Faecalibacterium prausnitzii strains
isolated from healthy volunteers: a step forward in the use of F.
prausnitzii as a next-generation probiotic. Front Microbiol.
2017;8:1226.
[39] Ze X, Duncan SH, Louis P, et al. Ruminococcus bromii is a
keystone species for the degradation of resistant starch in the
human colon. ISME J. 2012;6(8):1535-43.
[40] Ze X, Le Mougen F, Duncan SH, et al. Some are more equal
than others: the role of "keystone" species in the degradation of
recalcitrant substrates. Gut Microbes. 2013;4(3):236-40.
[41] Salonen A, Lahti L, Salojärvi J, et al. Impact of diet and
individual variation on intestinal microbiota composition and
fermentation products in obese men. ISME J. 2014;8(11):2218-30.
[42] Venkataraman A, Sieber JR, Schmidt AW, et al. Variable
responses of human microbiomes to dietary supplementation with
resistant starch. Microbiome. 2016;4(1):33.
[43] Flint HJ, Scott KP, Duncan SH, et al. Microbial degradation of
complex carbohydrates in the gut. Gut Microbes.
2012;3(4):289-306.
786
